Hamid Al-Mondhiry

Hamid Al-Mondhiry is a Professor in the Department of Medicine at Penn State Cancer Institute, specializing in Blood and Vascular Disorders. His research addresses critical aspects of hematology and coagulation disorders.

Research Interests

Dr. Al-Mondhiry’s work focuses on hemostasis, thrombosis, and blood stasis, with significant contributions to acquired hemophilia A and acute myeloid leukemia. His studies examine genetic mutations like Factor V Leiden and prothrombin G20210A in thrombosis recurrence, therapeutic applications of recombinant activated factor VII, and demographic trends in hemophilia patients.

Scientific Trends

His recent articles (2016-2020) emphasize clinical outcomes in hemophilia treatment, genetic abnormalities in leukemia, and population-based registry studies. Keywords span medicine, hematology, genetics, and thrombosis.

Scientific Awards

No specific awards or honors were explicitly mentioned in the provided texts.

Research Output

• 2020: Prospective cohort study on acquired hemophilia A treatment
• 2019: Chromosome rearrangements in leukemia
• 2019: Thrombosis recurrence risk in Factor V Leiden
• 2016: Patient demographics in U.S. hemophilia registries
• 2016: Recombinant factor VII efficacy in bleeding episodes